These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 7819721)

  • 21. Influence of apolipoprotein E genotypes on plasma lipid and lipoprotein concentrations: results from a segregation analysis in pedigrees with molecularly defined familial hypercholesterolemia.
    Friedlander Y; Leitersdorf E
    Genet Epidemiol; 1996; 13(2):159-77. PubMed ID: 8722744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation.
    Alonso R; Andres E; Mata N; Fuentes-Jiménez F; Badimón L; López-Miranda J; Padró T; Muñiz O; Díaz-Díaz JL; Mauri M; Ordovás JM; Mata P;
    J Am Coll Cardiol; 2014 May; 63(19):1982-9. PubMed ID: 24632281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lp(a) catabolism in hypercholesterolaemic individuals.
    Knight BL
    Chem Phys Lipids; 1994 Jan; 67-68():233-9. PubMed ID: 8187218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia.
    Pisciotta L; Sallo R; Rabacchi C; Wunsch A; Calandra S; Bertolini S
    Nutr Metab Cardiovasc Dis; 2012 Oct; 22(10):831-5. PubMed ID: 21920719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E polymorphism and heterozygous familial hypercholesterolemia. Sex-specific effects.
    Ferrières J; Sing CF; Roy M; Davignon J; Lussier-Cacan S
    Arterioscler Thromb; 1994 Oct; 14(10):1553-60. PubMed ID: 7918304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoprotein(a) as a risk factor for calcific aortic valvulopathy in heterozygous familial hypercholesterolemia.
    Vuorio A; Watts GF; Kovanen PT
    Atherosclerosis; 2019 Feb; 281():25-30. PubMed ID: 30616181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia.
    Olmastroni E; Gazzotti M; Averna M; Arca M; Tarugi P; Calandra S; Bertolini S; Catapano AL; Casula M;
    J Am Heart Assoc; 2023 May; 12(10):e029223. PubMed ID: 37183858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoprotein(a) in Familial Hypercholesterolemia With Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Gain-of-Function Mutations.
    Tada H; Kawashiri MA; Yoshida T; Teramoto R; Nohara A; Konno T; Inazu A; Mabuchi H; Yamagishi M; Hayashi K
    Circ J; 2016; 80(2):512-8. PubMed ID: 26632531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Segregation analysis of plasma lipoprotein(a) levels in pedigrees with molecularly defined familial hypercholesterolemia.
    Friedlander Y; Leitersdorf E
    Genet Epidemiol; 1995; 12(2):129-43. PubMed ID: 7607414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.
    Torres AL; Moorjani S; Vohl MC; Gagné C; Lamarche B; Brun LD; Lupien PJ; Després JP
    Atherosclerosis; 1996 Sep; 126(1):163-71. PubMed ID: 8879444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation.
    Ferrières J; Lambert J; Lussier-Cacan S; Davignon J
    Circulation; 1995 Aug; 92(3):290-5. PubMed ID: 7634440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterozygous familial hypercholesterolaemia: the influence of the mutation type of the low-density-lipoprotein receptor gene and PvuII polymorphism of the normal allele on serum lipid levels and response to lovastatin treatment.
    Vuorio AF; Ojala JP; Sarna S; Turtola H; Tikkanen MJ; Kontula K
    J Intern Med; 1995 Jan; 237(1):43-8. PubMed ID: 7830029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives, and unrelated control populations.
    Mbewu AD; Bhatnagar D; Durrington PN; Hunt L; Ishola M; Arrol S; Mackness M; Lockley P; Miller JP
    Arterioscler Thromb; 1991; 11(4):940-6. PubMed ID: 1829633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
    Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
    Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A functional polymorphism in the promoter region of the microsomal triglyceride transfer protein (MTP -493G/T) influences lipoprotein phenotype in familial hypercholesterolemia.
    Björn Lundahl ; Leren TP; Ose L; Hamsten A; Karpe F
    Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1784-8. PubMed ID: 10894817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial.
    Alaupovic P; Fesmire JD; Hunnighake D; Domanski M; Forman S; Knatterud GL; Forrester J; Herd JA; Hoogwerf B; Campeau L; Gobel FL
    Atherosclerosis; 1999 Oct; 146(2):369-79. PubMed ID: 10532693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study on apoE gene polymorphism in Chinese type II b hyperlipidemia].
    Zhang X; Bai H; Liu B; Fan P; Zhang R; Xu Y; Yao J; Zhu H
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Jun; 32(2):179-82. PubMed ID: 12600078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Lipoprotein(a) on the Diagnosis of Familial Hypercholesterolemia: Does It Make a Difference in the Clinic?
    Chan DC; Pang J; Hooper AJ; Bell DA; Burnett JR; Watts GF
    Clin Chem; 2019 Oct; 65(10):1258-1266. PubMed ID: 31307996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial hypercholesterolemia and apolipoprotein E4.
    Eto M; Watanabe K; Chonan N; Ishii K
    Atherosclerosis; 1988 Aug; 72(2-3):123-8. PubMed ID: 3214464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of growth hormone on low-density lipoprotein cholesterol and lipoprotein (a) levels in familial hypercholesterolemia.
    Tonstad S; Sundt E; Ose L; Hagve TA; Fruchart JC; Bard JM; Edén S
    Metabolism; 1996 Nov; 45(11):1415-21. PubMed ID: 8931648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.